Comparative Analysis of Respiratory Virus Infections: Pathogenesis, Clinical Outcomes, and Therapeutic Approaches for COVID-19, RSV, and Influenza
*Corresponding Author: Suchismita D, Department of Physiotherapy, Monash University, India, Email: suchi263@gmail.comReceived Date: Oct 01, 2024 / Published Date: Oct 31, 2024
Citation: Suchismita D (2024) Comparative Analysis of Respiratory VirusInfections: Pathogenesis, Clinical Outcomes, and Therapeutic Approaches forCOVID-19, RSV, and Influenza. J Pulm Res Dis 8: 219.
Copyright: © 2024 Suchismita D. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Abstract
Respiratory viral infections, including COVID-19, Respiratory Syncytial Virus (RSV), and Influenza, continue to be major public health concerns worldwide. These viruses share common clinical presentations, yet differ significantly in their pathogenesis, clinical outcomes, and available therapeutic interventions. This article provides a comparative analysis of COVID-19, RSV, and Influenza, highlighting the underlying mechanisms of infection, disease progression, and the current therapeutic strategies. We aim to elucidate the distinctive and overlapping characteristics of these respiratory viruses, with a focus on diagnostic challenges, clinical management, and the impact of public health measures. Understanding these differences and similarities will aid in improving treatment protocols and preparedness for future viral pandemics.
